CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Market Share Analysis
3.6. Brand Share Analysis
3.7. Value Chain Analysis
3.8. Regulatory Guidelines
3.9. Key Regulation Analysis
CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Kits
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS
5.1. Overview
5.1.1. Market size and forecast
5.2. Obesity
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Diabetes
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Cardiovascular Diseases
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Cancer Research
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Online Platforms
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hospitals and Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Applications
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Applications
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Applications
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Applications
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Applications
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Applications
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Applications
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Applications
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Spain
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Applications
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Italy
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Applications
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Applications
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Applications
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Applications
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Applications
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Applications
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. South Korea
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Applications
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. Australia
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Applications
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Applications
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Applications
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Applications
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. UAE
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Applications
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Applications
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. South Africa
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Applications
7.5.5.4.3. Market size and forecast, by End User
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by Product Type
7.5.5.5.2. Market size and forecast, by Applications
7.5.5.5.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Cura Integrative Medicine
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.2. Holistic Health
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.3. Metagenics, Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.4. GX Sciences Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.5. The Gene Box
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.6. Nutrigenomix Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.7. Xcode Life
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.8. DNA Life
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.9. Interleukin Genetics
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.10. Genova Diagnostics
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
| ※参考情報 ニュートリゲノミクスとは、個人の遺伝子情報と栄養摂取の相互作用を研究する分野です。この分野は、食事が遺伝子発現に与える影響を調査し、個々の遺伝的背景に基づいた最適な栄養戦略を提案することを目指しています。近年、生活習慣病や肥満の増加に伴い、個別化栄養の重要性が高まっており、ニュートリゲノミクスはその中心的な役割を果たしています。 ニュートリゲノミクスにはいくつかの種類がありますが、主に以下の3つに分類されます。まず、「遺伝子栄養学」です。これは個人が持つ遺伝子に基づいて、特定の栄養素や食材がどのように影響を及ぼすかを解析します。たとえば、ある遺伝子が特定の栄養素の吸収に関与している場合、染色体上の変異によってその効果が変わることがあります。これにより、その人にとっての適切な食事内容が異なり得るのです。 次に、「エピジェネティクス」に関連するニュートリゲノミクスがあります。エピジェネティクスは、DNAの配列に変化がない状態で遺伝子発現が変わるメカニズムを指し、環境要因や食事がこの状態に影響を与えることがあります。食事によってエピジェネティックな変化が引き起こされ、結果的に健康状態や病気リスクに繋がることが考えられています。 最後に「メタボロミクス」というアプローチがあります。これは、体内の代謝物質の変化やパターンを分析することで、食事と遺伝情報との関連を探るものです。代謝物質の変化は、栄養素の摂取状況や体内の生理的状態を反映するため、メタボロミクスを通じて個人に最適な食事やサプリメントの提案が可能になります。 ニュートリゲノミクスの主な用途としては、個別化栄養療法、疾病予防、健康維持が挙げられます。個人の遺伝情報に基づいた食事指導は、特定の病気のリスクを減少させる可能性があります。例えば、糖尿病や心血管疾患のリスク因子を持つ人に対して、食事内容を調整することで、病気の発症を防げることが期待されています。 また、ニュートリゲノミクスはスポーツ栄養にも応用されています。アスリートは個々の遺伝的背景に基づいて最適な栄養摂取を行うことで、パフォーマンスを向上させることができます。たとえば、特定の遺伝子に基づいて、持久力や筋力に対する栄養素の効果が変わることがあるため、これを活用したトレーニングや食事プランが作成されます。 ニュートリゲノミクスに関連する技術としては、次世代シーケンシングやバイオインフォマティクスがあります。次世代シーケンシングは、高速かつ低コストで遺伝情報を解析する技術であり、個々の遺伝子を簡単に解析できるため、ニュートリゲノミクスの発展を促進しています。バイオインフォマティクスは、大量の遺伝データやメタボロームデータを解析するための技術であり、遺伝子と栄養素の関係を明らかにするために不可欠です。 このように、ニュートリゲノミクスは遺伝子と栄養の相互作用に基づいて個別化された栄養計画を提供し、健康の向上や疾病予防に寄与する可能性があります。今後、この分野はますます発展し、個々のライフスタイルに合った栄養戦略を提供するための重要な基盤となるでしょう。私たちの健康を維持し、疾患を予防するために、ニュートリゲノミクスの知識を活用することが、今後の生活において重要になると言えるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
